Reversol

Active Ingredient(s): Edrophonium
FDA Approved: * May 13, 1988
Pharm Company: * ORGANON USA INC
Category: Myasthenic Syndrome

Edrophonium is a readily reversible acetylcholinesterase inhibitor. It prevents breakdown of the neurotransmitter acetylcholine and acts by competitively inhibiting the enzyme acetylcholinesterase, mainly at the neuromuscular junction. It is sold under the trade names Tensilon and Enlon (according to FDA Orange Book). Contents 1 Clinical uses 2 Chemistry 3 Pharmacokinetics 4 References 5 Further reading Clinical uses Edrophonium (by the so-called Tensilon test) is used to differentiate... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Related Brands

Drugs with the same active ingredients